SC
TFFP

Sepio Capital’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Sepio Capital’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,224
Closed -$347K – 366
2022
Q4 		$347K Buy
13,224
+622
+5% +$29.5K 0.03% 280
2022
Q3 		$1.28M Buy
12,602
+8,694
+222% +$1.18M 0.13% 164
2022
Q2 		$552K Buy
+3,908
New +$545K 0.06% 255
2021
Q1 		– Sell
-3,683
Closed -$1.5M – 407
2020
Q4 		$1.32M Buy
3,683
+301
+9% +$116K 0.11% 201
2020
Q3 		$1.56M Buy
+3,382
New +$954K 0.17% 126

Other funds holding TFFP

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Sepio Capital's TFFP Position: Q1 2023 in Review

Sepio Capital sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2023, closing a stake of 13,224 shares — an estimated $347K sold.

Sepio Capital first reported a position in TFFP in Q3 2020 and held it in 5 quarters. The position peaked at $1.56M in Q3 2020. 36 funds tracked by Wall St. Rank hold TFFP as of Q1 2023.

  • Sepio Capital reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Sepio Capital sold 13,224 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $347K.
  • Sepio Capital first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Sepio Capital's TFF Pharmaceuticals, Inc. Common Stock position peaked at $1.56M in Q3 2020.
  • 36 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Sepio Capital's 13F filing for Q1 2023, filed 10 May 2023.